<DOC>
	<DOCNO>NCT01053013</DOCNO>
	<brief_summary>This clinical research study investigational ( FDA IND-BB 10091 ) treatment patient pancreatic cancer ( stage ) advance colorectal cancer longer respond standard therapy . The treatment evaluate effect tumor growth . It consist placement ( implantation ) small bead contain mouse renal adenocarcinoma cell ( RENCA macrobeads ) . The cell macrobeads produce substance show slow stop growth tumor experimental animal veterinary patient . It test 31 human subject different type cancer Phase I safety trial . Phase II study patient colorectal , pancreatic prostate cancer progress .</brief_summary>
	<brief_title>Open-Label Phase 2 Efficacy Trial Cancer Macrobeads Patients With Treatment-Resistant Pancreatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Cancer pancreas , colon rectum Evidence metastasis Failed available therapy ( pancreatic cancer may treat without previous therapy ) Resolution toxic effect previous therapy Performance status ( ECOG PS ) 02 Adequate hematologic , coagulation ( INR 23 max ) , hepatic renal function Life expectancy least 6 week For female , negative pregnancy test Agrees contraceptive use study sexually active Informed consent Any condition presenting unacceptably high anesthetic surgical risk HIV positive Cognitive impairment preclude inform consent Surgical treatment chemotherapy within three week schedule macrobead implantation within four week bevacizumab ( similar drug ) , radiation therapy within four week schedule macrobead implantation Inadequate hematologic , coagulation ( INR &gt; 3 ) , hepatic , renal function Hepatic blood flow abnormality and/or largevolume ascites Concurrent cancer type except skin cancer ( exclude melanoma ) History allergic reaction mouse antigen Active infection , congestive heart failure , unstable angina , serious cardiac arrhythmia , psychiatric illness , difficult social situation permit reliable participation , active bleeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>macrobead</keyword>
	<keyword>biological</keyword>
	<keyword>mouse cell</keyword>
</DOC>